Crop Life Science's Days Sales Outstanding for the
six
months ended in Mar. 2026 was 162.91.
Crop Life Science's Days Inventory for the
six
months ended in Mar. 2026 was 210.36.
Crop Life Science's Days Payable for the
six
months ended in Mar. 2026 was 171.4.
Therefore, Crop Life Science's Cash Conversion Cycle (CCC) for the
six
months ended in Mar. 2026 was 201.87.
Crop Life Science (NSE:CLSL) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Crop Life Science Cash Conversion Cycle Related Terms
Crop Life Science Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Crop Life Science's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CLSL vs CTVA, CF, MOS: Cash Conversion Cycle Comparison
For the Agricultural Inputs subindustry, Crop Life Science's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crop Life Science Cash Conversion Cycle vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Crop Life Science's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Crop Life Science's Cash Conversion Cycle falls into.
Crop Life Science Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Crop Life Science's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crop Life Science (NSE:CLSL) has a Cash Conversion Cycle of 201.87 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Crop Life Science and its competitors.
Is Crop Life Science's Cash Conversion Cycle too high?
Crop Life Science's current Cash Conversion Cycle is 201.87. The Agriculture industry median Cash Conversion Cycle is 99.32. Crop Life Science's value of 201.87 is 103.3% above this industry median. Overall, Crop Life Science has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Cash Conversion Cycle compare to CTVA and CF?
Crop Life Science's Cash Conversion Cycle of 201.87 can be compared against companies in the Agriculture industry. The industry median Cash Conversion Cycle is 99.32. Crop Life Science's value of 201.87 is 103.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Agriculture company?
The median Cash Conversion Cycle among Agriculture companies is 99.32, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crop Life Science's current Cash Conversion Cycle of 201.87 is 103.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Crop Life Science and its competitors. For the Agriculture industry, the median Cash Conversion Cycle is 99.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current Cash Conversion Cycle is 201.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹54.99, compared to a current price of ₹43.00 — trading 21.8% below its estimated fair value. The current Cash Conversion Cycle is 201.87 and 103.3% above the Agriculture industry median of 99.32. Crop Life Science's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Cash Conversion Cycle is 201.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be undervalued.
The current stock price of ₹43.00 is trading 21.8% below its estimated GF Value™ of ₹54.99.
GuruFocus considers Crop Life Science to be Modestly Undervalued.
Key valuation signals for NSE:CLSL:
Cash Conversion Cycle: 201.87
GF Value™: ₹54.99 vs. price of ₹43.00 (21.8% below fair value)
Industry Position: 103.3% above the Agriculture median
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
58GF Score
Get the complete analysis for NSE:CLSL
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
